Susceptibilities of Neonatal Respiratory Isolates of Ureaplasma urealyticum to Antimicrobial Agents-Reference-Cited by-同舟云学术

Susceptibilities of Neonatal Respiratory Isolates of Ureaplasma urealyticum to Antimicrobial Agents

Published:1998-05 Issue:5 Volume:42 Page:1290-1292
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Matlow Anne¹²,Th’ng Cecilia³,Kovach Danuta¹,Quinn Patricia¹²⁴,Dunn Michael⁴,Wang Elaine⁵⁶

Affiliation:

1. Departments of Pediatric Laboratory Medicine1 and

2. Departments of Laboratory Medicine and Pathobiology2 and

3. Mycoplasma Laboratory, Ministry of Health Laboratory Services Branch,3Toronto, Ontario, Canada

4. Department of Neonatology, Women’s College Hospital,4University of Toronto, and

5. Pediatrics,5 The Hospital for Sick Children,

6. Pediatrics,6 and

Abstract

ABSTRACT Twenty-one neonatal respiratory isolates of Ureaplasma urealyticum were serotyped, and their susceptibilities to ciprofloxacin, gentamicin, chloramphenicol, erythromycin, azithromycin, and doxycycline were tested. Most patient strains were Ureaplasma urealyticum bv. parvum. Chloramphenicol, doxycycline, and azithromycin had the lowest MICs. This data may be useful when designing prophylactic or therapeutic trials of antibiotics for chronic lung disease of the newborn.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.42.5.1290

Reference19 articles.

1. Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns

2. Frequency and significance of isolation of Ureaplasma urealyticum and Mycoplasma hominis from cerebrospinal fluid and tracheal specimens from low birth weight infants.;Heggie A. D.;J. Pediatr.,1994

3. Susceptibilities of Mycoplasma hominis and Ureaplasma urealyticum to two new quinolones, sparfloxacin and WIN 57273

4. Kenny G. E. and F. D. Cartwright. 1993. Effect of pH inoculum size and incubation time on the susceptibility of Ureaplasma urealyticum to erythromycin in vitro. Clin. Infect. Dis. 17 (Suppl. 1) : S215–S218.

5. Safety, toleration, and pharmacokinetics of intravenous azithromycin

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potentially inappropriate prescribing in hospitalised children: a retrospective, cross-sectional study at a tertiary children’s hospital in China;BMJ Open;2023-05

2. Ureaplasma urealyticum;Principles and Practice of Pediatric Infectious Diseases;2023

3. Pharmacotherapy in Bronchopulmonary Dysplasia: What Is the Evidence?;Frontiers in Pediatrics;2022-03-09

4. Pharmacological Therapies for the Prevention of Bronchopulmonary Dysplasia;Updates on Neonatal Chronic Lung Disease;2020

5. U reaplasma;Bergey's Manual of Systematics of Archaea and Bacteria;2018-03-30